IGFBP2 and Obesity: To examine whether circulating IGFBP2 levels are altered during the course of fatty liver disease progression in humans, we measured IGFBP2 serum concentration in men with class III obesity, with histology confirmed hepatic pathological state (HepObster study) [23].